Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
42528783	s-apim10e	u/ml (—)	80	83	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Adverse effects, not elsewhere classified

51.45

34.40

1.0

1.1

—

Other and unspecified effects of external causes

35.10

32.71

1.0

1.1

—

Toxic effect of contact with venomous animals

+∞

21.92

1.1

0.0

—

Toxic effects of substances chiefly nonmedicinal as to source

+∞

21.89

1.1

0.0

—

Allergic rhinitis

19.79

14.97

1.1

—

Pollen allergy

18.79

12.79

1.1

—

Vasomotor and allergic rhinitis

10.29

11.57

1.1

1.0

—

Urticaria and erythema

10.01

10.48

1.1

—

Urticaria

10.01

9.98

1.1

—

Other medical care

11.76

9.48

1.1

—

Other and unspecified urticaria

14.02

8.67

1.1

—

Asthma (only as main-diagnosis)

6.13

8.40

1.1

1.0

—

Asthma (mode)

5.99

8.37

1.1

1.0

—

Asthma (only as main-diagnosis), excluding more controls

6.05

8.27

1.1

1.0

—

Exposure to other specified factors

3.96

7.75

1.0

—

Contact with other specified venomous animals

+∞

7.32

1.0

0.0

—

Persons encountering health services for specific procedures and health care

3.43

7.10

1.1

1.0

—

Pain in joint

4.78

6.99

1.0

—

Asthma

5.24

6.63

1.1

1.0

—

Asthma, excluding more controls

5.22

6.58

1.1

1.0

—

Other diseases of upper respiratory tract

3.70

5.90

1.0

—

Other specific joint derangements/joint disorders

3.57

5.83

1.0

—

Chronic diseases of tonsils and adenoids

3.87

5.81

1.0

—

Complications of medical and surgical care

3.60

5.62

1.1

1.0

—

Atopic dermatitis

3.54

5.61

1.0

—

Exposure to unspecified factor

3.08

5.57

1.0

—

Dermatitis and eczema

2.98

5.26

1.1

1.0

—

Allergic asthma (mode)

11.19

4.72

1.1

1.0

—

Allergic asthma (mode), excluding more controls

11.19

4.72

1.1

1.0

—

Other external causes of accidental injury

4.17

4.59

1.1

1.0

—

Asthma and allergy, excluding more controls

13.83

4.54

1.0

—

Tonsillectomy and adenotomy

3.38

4.52

1.1

1.0

—

Asthma, including avohilmo

2.70

4.37

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

3.72

4.35

1.0

—

Type of accident

7.50

4.35

1.0

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.00

4.33

1.1

1.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.11

4.19

1.1

1.0

—

Medical observation and evaluation for suspected diseases and conditions

5.11

4.13

1.0

1.1

—

Special screening examination for infectious and parasitic diseases

7.37

4.06

1.0

1.1

—

Tramadol

3.28

3.93

1.0

—

Allergic contact dermatitis

12.01

3.76

1.0

—

Other diseases of liver

12.01

3.76

1.0

1.2

—

Asthma, hospital admissions , main diagnosis only

2.74

3.67

1.1

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

4.67

3.60

1.0

1.1

—

Examination and observation for other reasons

4.90

3.56

1.0

1.1

—

Codeine

2.79

3.52

1.1

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

5.96

3.51

1.0

1.1

—

Complications of surgical and medical care, not elsewhere classified

2.58

3.46

1.1

1.0

—

Accidents

3.62

3.40

1.1

1.0

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

5.00

3.36

1.0

1.1

—

Gastro-oesophageal reflux disease

3.02

3.36

1.0

—

Asthma (diagnoses ohter than nonallergic)

2.62

3.35

1.1

1.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

5.72

3.34

1.0

1.1

—

Asthma, unspecified (mode)

4.43

3.21

1.0

—

Asthma, unspecified (mode), excluding more controls

4.40

3.19

1.0

—

Asthma/COPD (KELA code 203)

2.50

3.12

1.1

1.0

—

Chronic lower respiratory diseases

2.35

3.12

1.0

—

Transport accidents

4.55

3.07

1.0

—

Complications of procedures, not elsewhere classified

2.65

3.06

1.1

1.0

—

Migraine with aura and triptan purchases

7.51

3.05

1.0

—

Diseases of liver

5.00

3.05

1.0

1.1

—

Triptan medication for migraine, min. 3 purchases

2.65

3.01

1.0

1.1

—

Other intervertebral disc disorders

2.75

3.01

1.1

1.0

—

Leisure time condition

10.00

2.98

1.0

1.2

—

Other disorders of patella

10.00

2.98

1.0

—

Concussion

3.38

2.97

1.1

1.0

—

Oral corticosteroids

2.37

2.86

1.2

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

2.44

2.81

1.0

1.1

—

Triptan medication for migraine, single purchase ok

2.44

2.81

1.0

1.1

—

Opioids

2.53

2.80

1.1

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

4.01

2.76

1.0

1.1

—

Coxarthrosis

4.80

2.76

1.0

—

Disturbance of activity and attention

8.17

2.71

1.0

1.2

—

Sequelae of injuries, of poisoning and of other consequences of external causes

6.00

2.69

1.0

1.1

—

Atopic dermatitis, strict definition with reimbursement

3.78

2.67

1.0

—

Hyperkinetic disorders, excluding more controls

7.98

2.67

1.0

—

Metabolic disorders

2.47

2.66

1.0

1.1

—

Other dorsopathies, not elsewhere classified

2.37

2.63

1.1

1.0

—

Dermatitis

2.92

2.60

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

2.31

2.55

1.1

1.0

—

Other fall from one level to another

7.14

2.55

1.2

1.0

—

Sequelae of external causes of morbidity and mortality

5.46

2.54

1.0

1.1

—

Atopic dermatitis, strict definition

3.53

2.51

1.0

—

Hyperkinetic disorders

7.00

2.51

1.0

1.1

—

Other and unspecified tonsillitis

3.96

2.48

1.0

1.1

—

Other arthrosis

3.67

2.48

1.0

1.1

—

Viral and other specified intestinal infections

3.86

2.47

1.0

1.1

—

Intracranial trauma

2.81

2.47

1.1

1.0

—

Other pulmonary diagnosis

3.24

2.44

1.1

1.0

—

Excluding asthma or asthma-COPD overlap

3.24

2.44

1.1

1.0

—

COPD differential diagnosis

3.24

2.44

1.1

1.0

—

ILD differential diagnosis

3.24

2.44

1.1

1.0

—

Acute suppurative otitis media

4.36

2.44

1.1

1.0

—

Codeine or tramadol medication

2.19

2.39

1.1

1.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4.15

2.33

1.0

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3.24

2.31

1.0

—

Recurrent or chronic depression

2.86

2.27

1.0

—

Deviated nasal septum

4.61

2.27

1.0

1.1

—

Other disorders of urethra and urinary system

2.54

2.26

1.0

1.1

—

Diseases of the skin and subcutaneous tissue

2.36

2.20

1.0

—

Other diseases of hard tissues of teeth

0.00

2.19

0.0

1.1

—

Coxarthrosis [arthrosis of hip](FG)

3.52

2.18

1.0

—

Intracranial injury

2.67

2.17

1.1

1.0

—

Pure hypercholesterolaemia

2.97

2.17

1.0

—

Fracture of foot, except ankle

4.29

2.15

1.0

1.1

—

Infections with a predominantly sexual mode of transmission

2.74

2.08

1.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

5.00

2.07

1.0

1.1

—

Other and unspecified dermatitis

2.90

2.07

1.0

—

Arthrosis

2.74

2.04

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

4.00

2.03

1.0

1.1

—

Dorsopathies

2.13

2.01

1.1

1.0

—

Other nutritional deficiencies

2.23

2.00

1.0

1.1

—

Nerve, nerve root and plexus disorders

2.08

2.00

1.0

1.1

—

Viral and other specified intestinal infections

3.91

1.99

1.0

1.1

—

Disturbances of skin sensation

3.33

1.96

1.3

1.0

—

Excessive attrition of teeth

2.35

1.94

1.0

1.1

—

Primary coxarthrosis, bilateral

4.55

1.94

1.0

—

Other enthesopathies

4.55

1.94

1.0

—

Headache

2.31

1.94

1.2

1.0

—

Obesity due to excess calories

2.56

1.93

1.0

—

ILD medications

2.08

1.93

1.1

1.0

—

Cardiac arrhythmias

2.27

1.93

1.0

—

Lumbar disc prolapse

2.48

1.88

1.1

1.0

—

Migraine with aura

3.18

1.88

1.3

1.0

—

External causes of morbidity and mortality

3.51

1.84

1.1

1.0

—

Primary gonarthrosis, bilateral

3.15

1.82

1.0

—

Pain in limb

2.18

1.78

1.0

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

3.33

1.74

1.0

—

Glucagon-like peptide-1 (GLP-1) analogues

3.33

1.74

1.0

—

Obesity related asthma

3.33

1.74

1.0

—

Injuries to the shoulder and upper arm

2.18

1.73

1.0

—

Dizziness and giddiness

2.26

1.73

1.0

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

3.85

1.71

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.89

1.70

1.1

1.0

—

Injuries to the hip and thigh

2.88

1.68

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.98

1.64

1.0

1.1

—

Coxarthrosis, primary

2.82

1.63

1.0

—

Inflammatory bowel disease treatment related agents

1.90

1.59

1.1

1.0

—

Chronic sinusitis

2.69

1.57

1.0

—

Carpal tunnel syndrome

2.26

1.53

1.0

1.1

—

Artificial joint operation, meniscal resection

2.16

1.51

1.0

—

Other and unspecified disorders of vitreous body

2.82

1.48

1.0

—

Diseases of oesophagus, stomach and duodenum

1.91

1.47

1.0

1.1

—

Other joint disorders

1.98

1.46

1.0

—

Obesity, other/unspecified

2.50

1.45

1.0

—

Infections with a predominantly sexual mode of transmission

2.50

1.45

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

3.13

1.44

1.0

1.1

—

Injuries to the knee and lower leg

1.79

1.42

1.1

1.0

—

Other/unspecified dorsalgia

2.70

1.42

1.0

—

Obesity

2.03

1.42

1.0

1.1

—

Obesity and other hyperalimentation

2.03

1.41

1.0

1.1

—

Single spontaneous delivery

0.00

1.40

0.0

1.0

—

Other arrhythmias

2.06

1.40

1.0

—

Delivery

0.00

1.40

0.0

1.0

—

Disorders of synovium and tendon

2.25

1.39

1.0

1.1

—

Fracture of lower leg, including ankle

2.23

1.38

1.0

—

First line medication for Crohn's disease

1.88

1.38

1.1

1.0

—

Papulosquamous disorders

2.61

1.36

1.0

—

Cervical disc disorders

2.94

1.36

1.0

—

Other maternal disorders predominantly related to pregnancy

1.99

1.35

1.0

—

Injuries to the ankle and foot

1.93

1.33

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.82

1.32

1.0

1.1

—

Acute upper respiratory infections

1.82

1.31

1.1

1.0

—

Disorders of vitreous body

2.52

1.31

1.0

—

Disorders of vitreous body and globe

2.51

1.30

1.0

—

Dislocation, sprain and strain of joints and ligaments of knee

2.03

1.29

1.2

1.0

—

Gonarthrosis

2.40

1.29

1.3

1.0

—

Diseases of salivary glands

2.78

1.28

1.2

1.0

—

Personality disorders, excluding more controls

2.78

1.28

1.0

—

Abnormalities of breathing

1.85

1.28

1.0

1.1

—

Other functional intestinal disorders

2.42

1.24

1.0

—

Sciatica+with lumbago

2.23

1.24

1.0

—

Care involving use of rehabilitation procedures

2.23

1.24

1.0

—

General symptoms and signs

1.77

1.23

1.0

—

Other soft tissue disorders, not elsewhere classified

1.86

1.22

1.0

1.1

—

Delivery, wide proxy

0.00

1.22

0.0

1.0

—

Soft tissue disorders

1.79

1.20

1.0

1.1

—

Meniscus derangement

2.48

1.16

1.0

1.1

—

Gonarthrosis [arthrosis of knee](FG)

2.08

1.14

1.2

1.0

—

Other viral diseases, not elsewhere classified

2.49

1.14

1.4

1.1

—

Artrosis, including avohilmo

1.87

1.13

1.0

—

Use of hypnotics and sedatives

1.73

1.13

1.0

1.1

—

Maternal care for other conditions predominantly related to pregnancy

2.45

1.12

1.0

—

Other neurological diseases

2.03

1.12

1.0

—

Disorders of sclera, cornea, iris and ciliary body

2.00

1.12

1.0

—

Cerebrovascular diseases (FINNGEN)

2.53

1.12

1.4

1.1

—

Rotator cuff syndrome

2.28

1.10

1.0

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

1.89

1.10

1.2

1.0

—

Erysipelas

2.21

1.08

1.0

—

Neurotic, stress-related and somatoform disorders

1.72

1.08

1.1

1.0

—

Dorsalgia

1.79

1.07

1.0

—

Diverticular disease of intestine

2.05

1.07

1.0

—

Anxiety disorders

1.71

1.07

1.1

1.0

—

False labour

2.18

1.06

1.3

1.0

—

Postpartum care and examination

2.44

1.06

1.0

—

Erysipelas

2.02

1.05

1.0

—

Diseases of the respiratory system

2.51

1.05

1.2

1.0

—

Pregnancy examination and test

2.39

1.03

1.0

—

Personality disorders

2.27

1.03

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

1.81

1.03

1.2

1.0

—

Other headache syndromes

2.06

1.02

1.0

—

Angina pectoris

0.00

1.01

0.0

1.0

—

Other antidepressants

1.71

1.00

1.0

1.1

—

Shoulder lesions

1.88

0.99

1.0

1.1

—

Falls/tendency to fall

1.67

0.98

1.1

1.0

—

Mouth breathing

2.17

0.98

1.0

—

Visual disturbances and blindness

1.94

0.97

1.0

—

Intestinal infectious diseases

1.63

0.94

1.0

1.1

—

Haemorrhage in early pregnancy

2.16

0.92

1.0

—

Heart failure, not strict

2.01

0.91

1.0

—

Asthma, hospital admission 2, infections

1.85

0.91

1.0

—

Asthma-related infections

1.85

0.91

1.0

—

Other heart diseases, wide

1.64

0.91

1.0

1.1

—

Suppurative and unspecified otitis media

2.13

0.91

1.2

1.0

—

Fall on same level

1.57

0.87

1.0

1.1

—

Migraine

1.80

0.87

1.2

1.0

—

Temporomandibular joint disorders, including avohilmo

1.83

0.86

1.0

—

Infections of the skin and subcutaneous tissue

1.80

0.85

1.0

—

Anxiety disorders, excluding more controls

1.66

0.84

1.1

1.0

—

Chronic periodontitis, complicated

1.92

0.83

1.0

—

Unspecified fall

1.91

0.83

1.0

—

Constipation

1.73

0.83

1.0

1.1

—

Supervision of normal pregnancy

0.00

0.83

0.0

1.0

—

Lower back pain or/and sciatica

1.58

0.82

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

0.00

0.81

0.0

1.1

—

1.86

0.81

1.0

—

Episodal and paroxysmal disorders

1.57

0.81

1.0

—

Inflammatory bowel disease

0.00

0.79

0.0

1.0

—

Arthropathies

1.65

0.79

1.0

—

Persons encountering health services in other circumstances

1.81

0.78

1.0

—

Other viral diseases

1.80

0.78

1.3

1.0

—

Diseases of male genital organs

2.29

0.78

1.2

1.0

—

Inflammatory diseases of female pelvic organs

1.68

0.77

1.0

—

Allergic conjunctivitis

1.71

0.77

1.0

1.1

—

Open wound of wrist and hand

1.78

0.77

1.0

—

Any gastric operation

1.67

0.76

1.1

1.0

—

GASTRO-related operations

1.67

0.76

1.1

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

1.57

0.76

1.0

1.1

—

Atrial fibrillation and flutter

2.16

0.76

1.0

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.53

0.75

1.0

1.1

—

Hernia of abdominal wall

2.08

0.74

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2.06

0.74

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.55

0.73

1.0

—

Excessive, frequent and irregular menstruation

1.83

0.73

1.0

—

Syncope and collapse

2.04

0.73

1.0

—

Cerebrovascular diseases

1.82

0.73

1.3

1.0

—

Gonarthrosis,primary

1.63

0.73

1.0

1.1

—

Finngen Rheumatological endpoints

1.56

0.72

1.0

—

Keratitis

2.00

0.72

1.0

—

Low back pain

1.62

0.72

1.0

—

Bronchitis

1.52

0.72

1.1

1.0

—

Disorders of vestibular function (Vertigo)

1.97

0.71

1.0

—

Conjunctivitis

1.59

0.71

1.0

—

COPD/asthma related infections

1.53

0.71

1.0

—

COPD/asthma/ILD related infections

1.53

0.71

1.0

—

Complications predominantly related to the puerperium

1.92

0.70

1.0

—

Psychiatric diseases

1.56

0.70

1.1

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.56

0.70

1.0

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1.91

0.69

1.0

—

Disorders of choroid and retina

1.66

0.67

1.0

—

Fever of other and unknown origin

1.64

0.67

1.0

—

Other obstetric conditions, not elsewhere classified

1.65

0.67

1.0

—

Periapical abscess

1.79

0.66

1.0

—

1.49

0.64

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

1.74

0.64

1.0

—

Diseases of inner ear

1.73

0.64

1.0

—

Other disorders of veins

1.71

0.63

1.0

—

Cystitis

1.59

0.63

1.0

1.1

—

Type 2 diabetes, wide definition

1.65

0.63

1.0

—

Disorders of conjunctiva

1.53

0.62

1.0

—

Organic, including symptomatic, mental disorders

0.00

0.62

0.0

1.1

—

Viral infections characterized by skin and mucous membrane lesions

1.67

0.61

1.0

—

Disorders of lacrimal system

1.66

0.61

1.2

1.0

—

Disorders of tooth development and eruption

0.00

0.61

0.0

1.0

—

Any mental disorder

1.47

0.61

1.1

1.0

—

Aplastic and other anaemias

0.00

0.60

0.0

1.0

—

Persons encountering health services in other circumstances, wide

1.44

0.60

1.0

1.1

—

Insulin, fast-acting or short human

0.00

0.60

0.0

1.1

—

Insulin, fast-acting

0.00

0.60

0.0

1.0

—

STROKE

1.77

0.59

1.0

—

Visual disturbances

1.71

0.57

1.0

—

Anxiety (asthma-related co-morbidities)

1.42

0.52

1.1

1.0

—

Osteopathies and chondropathies

1.51

0.52

1.0

—

Codes for special purposes

1.50

0.51

1.0

—

Provisional assignment of new diseases of uncertain etiology

1.50

0.51

1.0

—

Intestinal infectious diseases

1.44

0.50

1.0

—

Acute tubulo-interstitial nephritis

1.55

0.49

1.0

—

Acute sinusitis

1.54

0.48

1.0

—

Used for control exclusion in common control thyroid runs

0.67

0.48

1.0

1.1

—

Fall on same level involving ice and snow

1.52

0.48

1.0

—

Autoimmune diseases

0.65

0.48

1.0

—

Other anxiety disorders

1.44

0.46

1.1

1.0

—

Diseases of the eye and adnexa

1.43

0.45

1.1

1.0

—

Disorders of breast

1.38

0.44

1.0

—

Depression or dysthymia

1.47

0.44

1.0

—

Malignant neoplasm, wide definition for exclusion

0.63

0.44

1.0

1.1

—

Antihypertensive medication - note that there are other indications

1.47

0.43

1.0

1.1

—

Mood disorders, excluding more controls

1.40

0.42

1.0

—

Depression

1.38

0.42

1.0

—

Hard cardiovascular diseases

1.40

0.42

1.0

—

Sleep apnoea

1.42

0.42

1.0

1.1

—

Other diseases of urinary system

1.40

0.42

1.0

1.1

—

Menorrhagia

1.54

0.42

1.0

—

Dementia

0.00

0.42

0.0

1.0

—

Unspecific neurodegenerative disorder

0.00

0.42

0.0

1.0

—

Malignant neoplasm of digestive organs

0.00

0.41

0.0

1.0

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.41

0.0

1.0

—

Non-invasive ventilation

0.00

0.41

0.0

1.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

0.41

0.0

1.0

—

Other/unspecified seropositive rheumatoid arthritis

0.00

0.41

0.0

1.0

—

Seropositive rheumatoid arthritis, wide

0.00

0.41

0.0

1.0

—

Haemorrhage from respiratory passages

0.00

0.41

0.0

1.1

—

Sulfasalazine

0.00

0.41

0.0

1.0

—

Heart failure and coronary heart disease

0.00

0.41

0.0

1.0

—

Other and unspecified anaemias

0.00

0.41

0.0

1.0

—

Other anaemias

0.00

0.41

0.0

1.0

—

Procreative management

1.49

0.40

1.0

—

Disorders of eyelid, lacrimal system and orbit

1.43

0.40

1.1

1.0

—

Leiomyoma of uterus

1.42

0.40

1.2

1.0

—

Persons with potential health hazards related to communicable diseases

1.46

0.40

1.4

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.41

0.40

1.0

—

Abnormal findings on examination of blood, without diagnosis

0.00

0.40

0.0

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.44

0.39

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.31

0.39

1.0

—

Sleep apnoea, including avohilmo

1.38

0.39

1.0

1.1

—

DVT of lower extremities and pulmonary embolism

0.00

0.39

0.0

1.0

—

Other diseases of intestines

1.33

0.37

1.0

1.1

—

Sleep disorders

1.35

0.37

1.0

—

Other bacterial diseases

1.36

0.37

1.0

1.1

—

All anxiety disorders

1.29

0.37

1.1

1.0

—

Diabetes mellitus in pregnancy

1.48

0.36

1.0

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.41

0.35

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.42

0.35

1.2

1.0

—

Polyarthropathies

1.35

0.34

1.0

—

Solid cancers, helper endpoint

0.68

0.34

1.0

1.1

—

Malignant neoplasm

0.67

0.34

1.0

1.1

—

Polycystic ovarian syndrome, consortium definition

0.66

0.34

1.0

—

Other (not insulin) diabetes medications

1.36

0.34

1.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

0.66

0.34

1.0

1.1

—

Insomnia

1.32

0.33

1.0

—

Hypertension, essential

1.38

0.33

1.0

1.1

—

Chronic periodontitis, including avohilmo

1.34

0.32

1.1

1.0

—

Type 2 diabetes, strict (exclude DM1)

1.35

0.32

1.0

1.1

—

Type 2 diabetes, definitions combined

1.35

0.32

1.0

1.1

—

Gestational diabetes (for exclusion)

1.39

0.32

1.0

1.1

—

Periodontitis

1.34

0.31

1.1

1.0

—

Diseases of the ear and mastoid process

1.28

0.31

1.1

1.0

—

Mood [affective] disorders

1.30

0.31

1.0

—

Mood disorders

1.29

0.31

1.0

—

Diseases of middle ear and mastoid

1.24

0.29

1.1

1.0

—

Chronic apical periodontitis

0.75

0.28

1.0

—

Biguanides

1.32

0.27

1.0

1.1

—

Endocrine, nutritional and metabolic diseases

1.33

0.27

1.0

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

0.65

0.26

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

0.69

0.26

1.0

—

Dentofacial anomalies [including malocclusion]

1.22

0.25

1.0

1.1

—

Autoimmune diseases related-to ILD

1.30

0.25

1.0

—

Neoplasms

0.72

0.25

1.0

—

Other bacterial diseases

1.19

0.25

1.0

—

Other disorders of ear

0.73

0.24

1.2

1.0

—

Pneumonia, organism unspecified

0.72

0.24

1.0

—

Endometriosis

1.40

0.24

1.0

—

Viral infections characterized by skin and mucous membrane lesions

0.71

0.24

1.0

—

Dental pulpitis, including avohilmo

1.26

0.24

1.0

—

Benzodiazepine use

1.25

0.23

1.0

—

Selective serotonin reuptake inhibitors

1.28

0.23

1.0

1.1

—

Other reaction to severe stress, and adjustment disorders

1.32

0.23

1.0

—

Diseases of the musculoskeletal system and connective tissue

1.25

0.23

1.2

1.0

—

Fracture of forearm

1.27

0.22

1.0

—

1.26

0.22

1.0

—

Dyspnoea

1.27

0.22

1.0

1.1

—

Gingivitis and periodontal diseases

0.78

0.22

1.1

1.0

—

Any dementia

0.00

0.22

0.0

1.0

—

Colorectal cancer

0.00

0.21

0.0

1.0

—

Paralytic ileus and intestinal obstruction

0.00

0.21

0.0

1.0

—

Poor fetal growth

0.00

0.21

0.0

1.0

—

Seborrhoeic keratosis

0.00

0.21

0.0

1.0

—

5-aminosalicylic acid

0.00

0.21

0.0

1.0

—

Type 1 diabetes, wide definition, subgroup 1

0.00

0.21

0.0

1.1

—

Pulmonary embolism

0.00

0.21

0.0

1.0

—

Pulmonary heart disease

0.00

0.21

0.0

1.0

—

Seropositive rheumatoid arthritis

0.00

0.21

0.0

1.0

—

Pulmonary heart disease, diseases of pulmonary circulation

0.00

0.21

0.0

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

0.21

0.0

1.0

—

Rheumatoid arthritis

0.00

0.21

0.0

1.0

—

Superficial injury of wrist and hand

0.00

0.21

0.0

1.1

—

L04AA Selective immunosuppressants

0.00

0.21

0.0

1.1

—

Nonorganic sleeping disorders, excluding more controls

0.00

0.21

0.0

1.0

—

Type 1 diabetes, wide definition

0.00

0.21

0.0

1.1

—

Nonorganic sleeping disorders

0.00

0.21

0.0

1.1

—

IBD patients in KELA-register

0.00

0.21

0.0

1.1

—

Ulcerative colitis

0.00

0.21

0.0

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

0.78

0.20

1.0

—

Autoimmune diseases excluding thyroid diseases

0.78

0.20

1.0

—

Unstable angina pectoris

0.00

0.20

0.0

1.0

—

Any dementia, excluding more controls

0.00

0.20

0.0

1.0

—

Spondylopathies

1.24

0.20

1.0

—

Inflammatory bowel disease, strict (require KELA)

0.00

0.20

0.0

1.1

—

Covid-19 suspected case

0.00

0.20

0.0

1.1

—

Injuries to the head

1.21

0.19

1.1

1.0

—

Hypertensive diseases (excluding secondary)

1.16

0.19

1.0

—

Symptoms and signs involving the urinary system

1.18

0.18

1.0

—

Injuries to the elbow and forearm

1.18

0.18

1.0

—

Medical abortion

1.11

0.16

1.0

—

Renal tubulo-interstitial diseases

1.12

0.16

1.0

—

Hypertensive diseases

1.18

0.16

1.0

1.1

—

Hypertension

1.18

0.16

1.0

1.1

—

Diseases of appendix

0.80

0.15

1.3

1.0

—

Neurological diseases

1.13

0.15

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.11

0.15

1.0

—

1.11

0.15

1.0

—

Sleep disorders (combined)

1.18

0.15

1.0

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

0.79

0.15

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

0.77

0.15

1.0

1.1

—

Diabetes, varying definitions

0.81

0.14

1.0

1.1

—

Diabetes mellitus

0.79

0.14

1.0

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.18

0.12

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.13

0.10

1.0

—

Mental and behavioural disorders due to psychoactive substance use

1.16

0.10

1.4

1.0

—

Necrosis of pulp, including avohilmo

1.11

0.09

1.0

1.1

—

Implicit Sepsis

1.05

0.08

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.14

0.08

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

1.13

0.08

1.0

1.1

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

0.82

0.08

1.0

—

Appendectomy

1.08

0.08

1.3

1.0

—

Cardiovascular diseases

0.83

0.08

1.0

—

Parasetamol

0.80

0.08

1.0

—

Pain in throat and chest

0.84

0.08

1.0

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

1.14

0.07

1.0

1.1

—

Acute appendicitis

0.84

0.07

1.3

1.0

—

Appendicitis, broad definition

0.80

0.07

1.3

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

0.84

0.07

1.0

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

1.09

0.07

1.0

1.1

—

Hypothyroidism, other/unspecified

0.82

0.07

1.0

1.1

—

Injuries to the wrist and hand

1.12

0.07

1.0

—

Diabetes medication

1.11

0.05

1.0

1.1

—

Disorders of the thyroid gland

1.08

0.02

1.0

1.1

—

Benign neoplasms

1.08

0.02

1.0

—

Certain infectious and parasitic diseases

1.07

0.00

1.0

—

Any event in cancer register

1.05

0.00

1.0

1.1

—

Influenza and pneumonia

1.01

0.00

1.0

—

All kidney diseases

1.05

0.00

1.0

—

COPD, hospital admissions 1, only main diagnosis

0.00

0.0

1.0

—

Statin medication

0.89

0.00

1.0

1.1

—

Other degenerative diseases of the nervous system

0.00

0.0

1.0

—

Other diseases of intestine

0.00

0.0

1.0

—

Symptoms and signs involving the digestive system and abdomen

1.00

0.00

1.0

—

Use of other anti-dementia drugs

0.00

0.0

1.0

—

Hypothyroidism, strict autoimmune

0.92

0.00

1.0

1.1

—

Thyrotoxicosis with diffuse goitre

0.00

0.0

1.0

—

Caries of enamel

0.95

0.00

1.0

—

Use of memantine

0.00

0.0

1.0

—

Acute appendicitis, no complications

0.94

0.00

1.4

1.0

—

Schizophrenia

0.00

0.0

1.2

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

0.00

0.0

1.0

—

Malignant melanoma, including Hilmo

0.00

0.0

1.0

—

Pediculosis, acariasis and other infestations

0.00

0.0

1.1

—

Benign neoplasm of ovary

0.00

0.0

1.0

—

Adenomyosis (Endometriosis of uterus)

0.00

-0.00

0.0

1.0

—

Alzheimer disease

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of corpus uteri

0.00

-0.00

0.0

1.0

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

-0.00

0.0

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

0.89

-0.00

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

0.95

-0.00

1.0

—

COPD, hospital admission 2, with asthma infections

0.00

-0.00

0.0

1.0

—

DVT of lower extremities

0.00

-0.00

0.0

1.0

—

Benign mammary dysplasia

0.00

-0.00

0.0

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.89

-0.00

1.0

—

Irregular menses

0.97

-0.00

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

-0.00

0.0

1.2

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

0.97

-0.00

1.0

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

-0.00

0.0

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

0.92

-0.00

1.0

—

All pneumoniae

0.91

-0.00

1.0

—

Pregnancy hypertension

1.02

-0.00

1.0

—

Coronary artery bypass grafting

0.00

-0.00

0.0

1.0

—

Type 2 diabetes

0.99

-0.00

1.0

1.1

—

Follicular cysts of skin and subcutaneous tissue

0.00

-0.00

0.0

1.1

—

Calcific aortic valvular stenosis, operated

0.00

-0.00

0.0

1.0

—

Colorectal adenocarcinoma

0.00

-0.00

0.0

1.0

—

Other hammer toe(s) (acquired)

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of colon, including Hilmo

0.00

-0.00

0.0

1.0

—

Use of anticholinesterases

0.00

-0.00

0.0

1.0

—

Later onset COPD

0.00

-0.00

0.0

1.0

—

Malignant melanoma

0.00

-0.00

0.0

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

0.93

-0.00

1.0

—

Scabies

0.00

-0.00

0.0

1.1

—

Other embolism and thrombosis

0.00

-0.00

0.0

1.0

—

Diabetic nephropathy, excluding more controls

0.00

-0.00

0.0

1.0

—

Mycoses

0.98

-0.00

1.0

—

Hernia

0.99

-0.00

1.0

1.1

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

-0.00

0.0

1.2

—

Abnormal findings on antenatal screening of mother

0.00

-0.00

0.0

1.0

—

Other noninflammatory disorders of vulva and perineum

0.00

-0.00

0.0

1.0

—

Coxibs

0.00

-0.00

0.0

1.0

—

Uterine polyps

0.00

-0.00

0.0

1.0

—

Chronic kidney disease

0.00

-0.00

0.0

1.2

—

N06DA Anticholinesterases

0.00

-0.00

0.0

1.0

—

Acne vulgaris

0.00

-0.00

0.0

1.2

—

Aortic aneurysm

0.00

-0.00

0.0

1.0

—

Pregnancy with abortive outcome

0.91

-0.00

1.0

—

Seropositive rheumatoid arthritis, strict definition

0.00

-0.00

0.0

1.0

—

Disease of hard tissues of teeth, NOS

0.98

-0.00

1.0

1.1

—

Complications of labour and delivery

0.88

-0.00

1.0

—

Abnormal serum enzyme levels

0.00

-0.00

0.0

1.0

—

Abdominal and pelvic pain

1.00

-0.00

1.0

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

0.00

-0.00

0.0

1.2

—

Alcohol abuse, main dg

0.00

-0.00

0.0

1.2

—

Insulin, fast-acting (human)

0.00

-0.00

0.0

1.1

—

Atrophic disorders of skin

0.00

-0.00

0.0

1.0

—

Gastrointestinal diseases

0.86

-0.00

1.2

1.0

—

Pain (limb, back, neck, head abdominally)

1.00

-0.00

1.0

—

Presence of other devices

0.00

-0.00

0.0

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

-0.00

0.0

1.0

—

Operations 2 for CAVS

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of corpus uteri, including Hilmo

0.00

-0.00

0.0

1.0

—

Calcific aortic valvular stenosis

0.00

-0.00

0.0

1.0

—

Other extrapyramidal and movement disorders in other diseases

0.00

-0.00

0.0

1.0

—

Malignant melanoma of skin, including Hilmo

0.00

-0.00

0.0

1.0

—

Other puerperal infections

0.00

-0.00

0.0

1.0

—

Diabetic retinopathy, strict definition

0.00

-0.00

0.0

1.0

—

Other or unspecified ileus, impaction or obstruction

0.00

-0.00

0.0

1.0

—

Acute laryngitis and tracheitis

0.00

-0.00

0.0

1.2

—

Phobic anxiety disorders

0.00

-0.00

0.0

1.0

—

Other (seronegative) rheumatoid arthritis, wide

0.00

-0.00

0.0

1.0

—

Degenerative diseases of the nervous system

0.00

-0.00

0.0

1.0

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

-0.00

0.0

1.1

—

Alzheimer disease, including avohilmo

0.00

-0.00

0.0

1.0

—

Biological medication for rheuma

0.00

-0.00

0.0

1.2

—

Psoriasis vulgaris

0.00

-0.00

0.0

1.2

—

Rheumatism, unspecified

0.00

-0.00

0.0

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

-0.00

0.0

1.0

—

Any reimbursement code in KELA

0.88

-0.00

1.2

1.1

—

Tumor necrosis factor alpha inhibitors

0.00

-0.00

0.0

1.2

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS